Literature DB >> 11433808

Quantification of left atrial appendage spontaneous echo contrast in patients with chronic nonalvular atrial fibrillation.

T Ito1, M Suwa, T Nakamura, S Miyazaki, A Kobashi, Y Kitaura.   

Abstract

OBJECTIVES: The left atrial (LA) appendage is the most common site of thrombus formation in patients with atrial fibrillation, and integrated backscatter allows the quantiative assessment of LA spontaneous echo contrast (SEC). Integrated backscatter was used to examine the significance of measuring appendage SEC, specifically in relation to echocardiographic variables implying thromboembolism, in patients with chronic nonvalvular atrial fibrillation.
METHODS: Fifty-two patients with chronic nonvalvular atrial fibrillation and no prior anticoagulant therapy (35 men, 17 women, mean age 66 +/- 7 years) underwent transesophageal echocardiography with integrated backscatter analysis. The LA and LA appendage integrated backscatter intensity were measured with the regions of interest placed in the LA cavity and the appendage, respectively. The integrated backscatter intensity values for these two chambers (corrected "LA" and "LA appendage" integrated backscatter intensity, respectively) were corrected using values from the left ventricular cavity.
RESULTS: The LA appendage integrated backscatter intensity values were available in 44 patients (85%). Overall, the corrected LA appendage integrated backscatter intensity was significantly increased compared with the corrected LA integrated backscatter intensity (2.8 +/- 2.2 vs 2.0 +/- 1.8 dB, p < 0.001). The corrected LA appendage integrated backscatter intensity was inversely correlated with the LA appendage velocity (r = -0.37, p < 0.05), but not with the LA dimension, appendage size, or left ventricular function. The corrected appendage integrated backscatter intensity (4.5 +/- 2.3 vs 2.4 +/- 1.9 dB, p < 0.01) and LA integrated backscatter intensity (3.2 +/- 2.1 vs 1.7 +/- 1.7 dB, p < 0.05) were higher in patients who had LA appendage thrombus (n = 8) than those who did not. With the corrected appendage integrated backscatter intensity set at > or = 2.5 dB, the sensitivity for the presence of appendage thrombus was 88% and the specificity was 64%.
CONCLUSIONS: Patients with chronic nonvalvular atrial fibrillation had a denser SEC in the LA appendage compared with SEC in the main LA cavity. The severity of the appendage SEC was influenced by the LA appendage function rather than its size. Quantification of SEC in the appendage, rather than main LA cavity, was more valuable for assessing embolic potential.

Entities:  

Mesh:

Year:  2001        PMID: 11433808

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  5 in total

1.  Transesophageal echocardiography of intracardiac thrombus in congenital heart disease and atrial flutter: the importance of thorough examination of the Fontan.

Authors:  Nida Yousef; Molly Philips; Ira Shetty; Vivian Wei Cui; Frank Zimmerman; David A Roberson
Journal:  Pediatr Cardiol       Date:  2014-04-20       Impact factor: 1.655

2.  Routine Transesophageal Echocardiography in Atrial Fibrillation Before Electrical Cardioversion to Detect Left Atrial Thrombosis and Echocontrast.

Authors:  Sebastian Feickert; Giuseppe D Ancona; Hüseyin Ince; Kristof Graf; Elias Kugel; Monica Murero; Erdal Safak
Journal:  J Atr Fibrillation       Date:  2020-10-31

Review 3.  Left atrial spontaneous echo contrast: relationship with clinical and echocardiographic parameters.

Authors:  Takahide Ito; Michihiro Suwa
Journal:  Echo Res Pract       Date:  2019-06-01

4.  Incremental diagnostic role of left atrial strain analysis in thrombotic risk assessment of nonvalvular atrial fibrillation patients planned for electrical cardioversion.

Authors:  Andrea Sonaglioni; Michele Lombardo; Gian Luigi Nicolosi; Elisabetta Rigamonti; Claudio Anzà
Journal:  Int J Cardiovasc Imaging       Date:  2021-01-03       Impact factor: 2.357

5.  Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report.

Authors:  Lucia Masarova; Jan Novak; Martin Pesl; Jiri Ondrasek; Jiri Semenka; Eva Simarova; Roman Panovsky
Journal:  BMC Cardiovasc Disord       Date:  2020-02-21       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.